Specifically, BAP1 typically promotes the activation of IFNβ and STING mediated by HIF-2α, which helps inhibit tumor growth through the activation of interferon stimulated gene factor 3 (ISGF3) (Langbein et al., 2022). The gene discussed is BAP1; the disease is neoplasm.